These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2887448)

  • 1. Regulation of growth inhibitory activity in transformed mouse embryo fibroblasts.
    Levine AE; Crandall CA; Brattain MG
    Exp Cell Res; 1987 Aug; 171(2):357-66. PubMed ID: 2887448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface features associated with differentiation-induction of methylcholanthrene-transformed AKR-2B fibroblasts by N,N-dimethylformamide.
    Marks ME; Ziober BL; Brattain MG
    Cancer Res; 1985 Mar; 45(3):1276-84. PubMed ID: 3855694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated growth factor levels in transformed mouse embryo cells treated with N,N-dimethylformamide.
    Levine AE; Hamilton DA; McRae LJ; Brattain MG
    Cancer Res; 1985 Jan; 45(1):108-11. PubMed ID: 2981156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of N,N-dimethylformamide and retinoic acid on transforming growth factor-beta induced mitogenesis in AKR-2B mouse embryo fibroblasts.
    Levine AE; Crandall CA
    Cancer Res; 1987 Aug; 47(16):4278-82. PubMed ID: 3496961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
    Tucker RF; Volkenant ME; Branum EL; Moses HL
    Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of normal growth control and membrane antigen composition in malignant cells by N,N-dimethylformamide.
    Chakrabarty S; McRae LJ; Levine AE; Brattain MG
    Cancer Res; 1984 May; 44(5):2181-5. PubMed ID: 6608991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in receptor occupancy and growth factor responsiveness induced by treatment of a transformed mouse embryo cell line with N,N-dimethylformamide.
    Levine AE; McRae LJ; Brattain MG
    Cancer Res; 1985 Dec; 45(12 Pt 1):6401-5. PubMed ID: 2998599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of transforming growth factor beta, N,N-dimethylformamide, and retinoic acid on transformed and nontransformed fibroblasts.
    Hoosein NM; Brattain DE; McKnight MK; Brattain MG
    Exp Cell Res; 1988 Mar; 175(1):125-35. PubMed ID: 3162213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cellular phosphoprotein profiles in transformation and redifferentiation of murine AKR embryonic fibroblastic cells.
    Chakrabarty S; Brattain MG
    Cancer Lett; 1985 Nov; 29(2):151-5. PubMed ID: 3865700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective phosphorylation of cytosol proteins associated with transformation and restoration of normal phenotype in AKR mouse embryo fibroblasts.
    Chakrabarty S; Jan Y; Son J; Miller CA; Brattain MG
    Cancer Res; 1985 May; 45(5):2170-6. PubMed ID: 3872713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of c-myc in a transformed cell line approaching stationary phase growth in culture.
    Mulder KM; Levine AE; Hinshaw XH
    Cancer Res; 1989 May; 49(9):2320-6. PubMed ID: 2706619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor production by chemically transformed cells.
    Moses HL; Branum EL; Proper JA; Robinson RA
    Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factors from human colonic carcinoma cells induced molecular alterations in untransformed mouse AKR embryo fibroblasts.
    Chakrabarty S; Brattain MG
    Cell Biol Int Rep; 1986 Nov; 10(11):891-5. PubMed ID: 3466722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of fibronectin synthesis and fibronectin binding during transformation and differentiation of mouse AKR fibroblasts.
    Varani J; Chakrabarty S
    J Cell Physiol; 1990 Jun; 143(3):445-54. PubMed ID: 2141611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells.
    Marks ME; Ziober BL; Brattain MG
    Cancer Res; 1986 Oct; 46(10):5248-58. PubMed ID: 3756877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.
    Tucker RF; Branum EL; Shipley GD; Ryan RJ; Moses HL
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6757-61. PubMed ID: 6208555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a serum-free culture system comparing growth factor requirements of transformed and untransformed cells.
    Mulder KM; Childress-Fields KE
    Exp Cell Res; 1990 Jun; 188(2):254-61. PubMed ID: 2185944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.
    Hoosein NM; Brattain DE; McKnight MK; Levine AE; Brattain MG
    Cancer Res; 1987 Jun; 47(11):2950-4. PubMed ID: 3471320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous maintenance of transformed fibroblasts under reduced serum conditions: utility as a model system for investigating growth factor-specific effects in nonquiescent cells.
    Mulder KM; Brattain MG
    J Cell Physiol; 1989 Mar; 138(3):450-8. PubMed ID: 2647770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
    Levine AE; Black B; Brattain MG
    J Cell Physiol; 1989 Mar; 138(3):459-66. PubMed ID: 2925796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.